JP2024544415A5 - - Google Patents
Info
- Publication number
- JP2024544415A5 JP2024544415A5 JP2024537407A JP2024537407A JP2024544415A5 JP 2024544415 A5 JP2024544415 A5 JP 2024544415A5 JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024544415 A5 JP2024544415 A5 JP 2024544415A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- approximately
- formula
- compound
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704.2 | 2021-12-24 | ||
| EP21217704 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544415A JP2024544415A (ja) | 2024-11-29 |
| JP2024544415A5 true JP2024544415A5 (https=) | 2026-01-05 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537407A Pending JP2024544415A (ja) | 2021-12-24 | 2022-12-23 | 動物における呼吸器疾患の治療のための注射用医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (https=) |
| EP (1) | EP4452226A1 (https=) |
| JP (1) | JP2024544415A (https=) |
| CN (1) | CN118632684A (https=) |
| AR (1) | AR128074A1 (https=) |
| AU (1) | AU2022420882A1 (https=) |
| CA (1) | CA3242451A1 (https=) |
| MX (1) | MX2024007862A (https=) |
| WO (1) | WO2023118557A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| WO2025133098A2 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
| WO2025133088A1 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| BR112019012861A2 (pt) | 2016-12-23 | 2019-12-10 | Intervet Int Bv | compostos para o tratamento de doença respiratória bovina ou suína |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024544415A5 (https=) | ||
| KR100752836B1 (ko) | 분산성 약학 조성물 | |
| CN111295202B (zh) | 治疗甲癣的外用制剂 | |
| US20030219472A1 (en) | Compositions and method for transmucosal drug delivery and cryoprotection | |
| CN1239427A (zh) | Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用 | |
| RU2018119295A (ru) | Фармацевтические составы для местного применения для лечения связанных с воспалением состояний | |
| JP5377326B2 (ja) | ウシ類と他の動物における炎症を処置するための薬学的組成物および方法 | |
| KR102568082B1 (ko) | 안과용 조성물 | |
| CA2728727C (en) | Pharmaceutical transdermal compositions and method for treating inflammation in cattle | |
| CN105813651A (zh) | 异噁唑啉组合物及其在预防或治疗动物的寄生虫侵袭中的用途 | |
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| JP2020011967A5 (https=) | ||
| JP2010195823A (ja) | 小動物用の注射可能な獣医用組成物 | |
| JPWO2003105841A1 (ja) | 抗真菌医薬組成物 | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2022538505A5 (https=) | ||
| EP4126057B1 (en) | Composition having improved voluntary acceptance | |
| JP2022176219A (ja) | 外用製剤 | |
| WO2015108045A1 (ja) | 経皮投与用外用剤 | |
| JP6128572B2 (ja) | ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸を含有する水性液体組成物 | |
| RU2014141341A (ru) | Паралитический яд моллюсков | |
| RU2024120685A (ru) | Инъекционная фармацевтическая композиция для лечения респираторных заболеваний у животных | |
| JP2007519701A5 (https=) | ||
| RU2742879C1 (ru) | Фармацевтическая композиция для лечения псориаза | |
| JP2008143894A (ja) | 坐剤 |